By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – A*STAR Institute of Microelectronics today announced it has signed an agreement to advance QuantuMDx's DNA sequencing nanowire biosensor to the point of commercialization.

QMDx, based in the UK, is developing a handheld all-in-one DNA sequencer, which is currently in prototype. The collaboration leverages Singapore-based A*STAR's silicon-based nanowire technology to develop technology for the simultaneous detection of large numbers of difference cells and biomaterials.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.